Global Patent Index - EP 1461074 A4

EP 1461074 A4 20060111 - AGENTS FOR ENHANCING THE IMMUNE RESPONSE

Title (en)

AGENTS FOR ENHANCING THE IMMUNE RESPONSE

Title (de)

MITTEL ZUR VERSTÄRKUNG DER IMMUNANTWORT

Title (fr)

AGENTS DESTINES A AUGMENTER LA REPONSE IMMUNITAIRE

Publication

EP 1461074 A4 20060111 (EN)

Application

EP 02752793 A 20020812

Priority

  • US 0225511 W 20020812
  • US 31138701 P 20010813
  • US 14296602 A 20020513

Abstract (en)

[origin: WO03015694A2] The invention relates to an immunogenic composition and methods of making and using the composition. The immunogenic composition contains a directing molecule, a stimulant and an immunogen. The stimulant and directing molecule are chemically distinct. The stimulant and immunogen are present in relative amounts to result in an improved immune response relative to that resulting from the immunogen and just one of the directing molecule or stimulant.

IPC 1-7

A61K 39/00; A61K 39/118; A61K 39/39; A61K 47/48

IPC 8 full level

A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/118 (2006.01); A61K 39/12 (2006.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); A61K 47/48 (2006.01); A61P 37/02 (2006.01); C07K 16/12 (2006.01); C12P 21/08 (2006.01)

CPC (source: EP US)

A61K 39/118 (2013.01 - EP US); A61K 39/39 (2013.01 - EP US); A61K 39/39541 (2013.01 - EP US); A61P 37/02 (2017.12 - EP); C07K 16/125 (2013.01 - EP US); A61K 2039/55516 (2013.01 - EP US); A61K 2039/55561 (2013.01 - EP US); A61K 2039/55577 (2013.01 - EP US)

Citation (search report)

  • [XY] US 5750119 A 19980512 - SRIVASTAVA PRAMOD K [US]
  • [Y] WO 9633739 A1 19961031 - SMITHKLINE BEECHAM BIOLOG [BE], et al
  • [Y] EP 0658111 A1 19950621 - CAMBRIDGE BIOTECH CORP [US]
  • [Y] WO 9220316 A2 19921126 - UNIV CONNECTICUT [US], et al
  • [Y] US 6027732 A 20000222 - MOREIN BROR [SE], et al
  • [PX] WO 0211669 A2 20020214 - ANTIGENICS LLC [US]
  • [A] EP 0245078 A2 19871111 - CONNAUGHT LAB [CA]
  • [XY] HAYNES B F ET AL: "HIV vaccine developments at Duke University Medical Center", IMMUNOLOGIC RESEARCH, KARGER, BASEL, CH, vol. 22, no. 2-3, 2000, pages 263 - 269, XP002978513, ISSN: 0257-277X
  • [XY] LODE HOLGER N ET AL: "Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 96, no. 4, 16 February 1999 (1999-02-16), pages 1591 - 1596, XP002345519, ISSN: 0027-8424
  • [XY] RODGERS E S ET AL: "THE POTENTIAL OF POLYMERIC NANOPARTICLES TO INCREASE THE IMMUNOGENICITY OF THE HAPTEN CLENBUTEROL", FOOD AND AGRICULTURAL IMMUNOLOGY, vol. 9, no. 3, September 1997 (1997-09-01), pages 159 - 166, XP009044145, ISSN: 0954-0105
  • [XY] LEES C J ET AL: "Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 19, no. 2-3, 15 September 2000 (2000-09-15), pages 158 - 162, XP004228822, ISSN: 0264-410X
  • [XY] TODA S ET AL: "HIV-1-specific cell-mediated immune responses induced by DNA vaccination where enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody", IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBLICATIONS, GB, vol. 92, no. 1, 1997, pages 111 - 117, XP002977986, ISSN: 0019-2805
  • [Y] HELLING F ET AL: "GD3 VACCINES FOR MELANOMA: SUPERIOR IMMUNOGENICITY OF KEYHOLE LIMPET HEMOCYANIN CONJUGATE VACCINES", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 54, 1 January 1994 (1994-01-01), pages 197 - 203, XP002934626, ISSN: 0008-5472
  • [Y] HEIJNEN-IA ET AL: "Antigen targeting to myeloid-specific human Fc-gamma-RI-CD64 cd", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 97, no. 2, 15 January 1996 (1996-01-15), pages 331 - 338, XP002081335, ISSN: 0021-9738
  • [Y] WITHOFF S ET AL: "Bi-specific antibody therapy for the treatment of cancer.", CURRENT OPINION IN MOLECULAR THERAPEUTICS. FEB 2001, vol. 3, no. 1, February 2001 (2001-02-01), pages 53 - 62, XP001085091, ISSN: 1464-8431
  • [Y] GUYRE P M ET AL: "Increased potency of Fc-receptor-targeted antigens.", CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII. 1997 NOV-DEC, vol. 45, no. 3-4, November 1997 (1997-11-01), pages 146 - 148, XP002345172, ISSN: 0340-7004
  • [Y] COX J C ET AL: "Adjuvants--a classification and review of their modes of action", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 15, no. 3, February 1997 (1997-02-01), pages 248 - 256, XP004094403, ISSN: 0264-410X
  • [Y] BINDER R J ET AL: "Adjuvanticity of alpha 2-macroglobulin, an independent ligand for the heat shock protein receptor CD91.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 APR 2001, vol. 166, no. 8, 15 April 2001 (2001-04-15), pages 4968 - 4972, XP002965476, ISSN: 0022-1767
  • [Y] MAURI DAVIDE ET AL: "Improved sensitization of antigen-presenting cells with transferrin-bound peptides: Advantages in competition for antigen presentation", CELLULAR IMMUNOLOGY, vol. 158, no. 1, 1994, pages 59 - 70, XP009053943, ISSN: 0008-8749
  • [Y] SCARDINO A ET AL: "Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes", IMMUNOLOGY, vol. 81, no. 1, 1994, pages 167 - 170, XP009054026, ISSN: 0019-2805
  • [Y] ENGERING A J ET AL: "THE MANNOSE RECEPTOR FUNCTIONS AS A HIGH CAPACITY AND BROAD SPECIFICITY ANTIGEN RECEPTOR IN HUMAN DENDRITIC CELLS", EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 27, no. 9, September 1997 (1997-09-01), pages 2417 - 2425, XP008005700, ISSN: 0014-2980
  • [Y] CRUZ P E ET AL: "A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 17, no. 9-10, 5 March 1999 (1999-03-05), pages 1091 - 1099, XP004158230, ISSN: 0264-410X
  • [Y] TEST SAMUEL T ET AL: "Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide", INFECTION AND IMMUNITY, vol. 69, no. 5, May 2001 (2001-05-01), pages 3031 - 3040, XP002345171, ISSN: 0019-9567
  • [Y] CARROLL M C ET AL: "Complement and the immune response", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, vol. 9, no. 1, February 1997 (1997-02-01), pages 64 - 69, XP004327233, ISSN: 0952-7915
  • [A] MITSUDA SHINOBU ET AL: "Receptor-linked antigen delivery system: Importance of autologous alpha-2-macroglobulin in the development of peptide vaccine", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 216, no. 1, 1995, pages 399 - 405, XP002318103, ISSN: 0006-291X
  • [A] DIEBOLD S S ET AL: "MHC class II presentation of endogenously expressed antigens by transfected dendritic cells", GENE THERAPY, vol. 8, no. 6, March 2001 (2001-03-01), pages 487 - 493, XP002345183, ISSN: 0969-7128
  • [A] STAHL P D ET AL: "The mannose receptor is a pattern recognition receptor involved in host defense", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, vol. 10, no. 1, February 1998 (1998-02-01), pages 50 - 55, XP004313620, ISSN: 0952-7915
  • [A] TAN ET AL: "MANNOSE RECEPTOR-MEDIATED UPTAKE OF ANTIGENS STRONGLY ENHANCES HLA CLASS II-RESTRICTED ANTIGEN PRESENTATION BY CULTURED DENDRITIC CELL", EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 27, September 1997 (1997-09-01), pages 2426 - 2435, XP000877415, ISSN: 0014-2980
  • [A] KLERX J P A M ET AL: "SIMPLE SUGARS WITH AFFINITY FOR THE MACROPHAGE ASIALOGLYCOPROTEIN RECEPTOR ARE ADJUVANTS FOR THE HUMORAL IMMUNE RESPONSE TO NEURAMINIDASE-TREATED SHEEP ERYTHROCYTES", JOURNAL OF IMMUNOLOGY, vol. 136, no. 1, 1986, pages 73 - 75, XP002345173, ISSN: 0022-1767
  • [A] BEEKMAN N J C M ET AL: "Highly immunogenic and fully synthetic peptide-carrier constructs targetting GNRH", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 17, no. 15-16, 9 April 1999 (1999-04-09), pages 2043 - 2050, XP004165054, ISSN: 0264-410X
  • [A] CHANG J-S ET AL: "Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 17, no. 11-12, March 1999 (1999-03-01), pages 1540 - 1548, XP004158283, ISSN: 0264-410X
  • [A] SCHEEPERS K ET AL: "Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes.", MEDICAL MICROBIOLOGY AND IMMUNOLOGY. NOV 1994, vol. 183, no. 5, November 1994 (1994-11-01), pages 265 - 278, XP009053793, ISSN: 0300-8584
  • [A] SINGH M ET AL: "ADVANCES IN VACCINE ADJUVANTS", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 17, no. 11, November 1999 (1999-11-01), pages 1075 - 1081, XP000941305, ISSN: 1087-0156
  • [A] MOREIN B ET AL: "Immunomodulation by Iscoms, Immune Stimulating Complexes", METHODS : A COMPANION TO METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC., NEW YORK, NY, US, vol. 19, no. 1, September 1999 (1999-09-01), pages 94 - 102, XP004466811, ISSN: 1046-2023
  • [A] LANZAVECCHIA A: "RECEPTOR-MEDIATED ANTIGEN UPTAKE AND ITS EFFECT ON ANTIGEN PRESENTATION TO CLASS II-RESTRICTED T LYMPHOCYTES", PAUL, W. E. (ED.). ANNUAL REVIEW OF IMMUNOLOGY, VOL. 8. X+819P. ANNUAL REVIEWS, INC.: PALO ALTO, CALIFORNIA, USA. ILLUS SERIES : ANNUAL REVIEW OF IMMUNOLOGY (ISSN 0732-0582), 1990, pages 773 - 794, XP001207537, ISSN: 0-8243-3008-0
  • [A] KIM-SK ET AL: "Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 19, no. 4-5, 15 October 2000 (2000-10-15), pages 530 - 537, XP004218125, ISSN: 0264-410X
  • [A] MAHON B P: "The rational design of vaccine adjuvants for mucosal and neonatal immunization", CURRENT MEDICINAL CHEMISTRY, vol. 8, no. 9, July 2001 (2001-07-01), pages 1057 - 1074, XP002345185, ISSN: 0929-8673
  • [PA] MOINGEON P ET AL: "TOWARDS THE RATIONAL DESIGN OF TH1 ADJUVANTS", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 19, no. 31, 2001, pages 4363 - 4372, XP004296096, ISSN: 0264-410X
  • [T] REGECZY NORA ET AL: "Reactivity of new adhesion molecules on lymphocytes from patients with chronic graft versus host disease.", ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, vol. 50, no. 1, 2003, pages 55 - 65, XP009054130, ISSN: 1217-8950
  • See references of WO 03015694A2

Citation (examination)

  • US 6143297 A 20001107 - BLUESTONE JEFFERY A [US]
  • DE 19835633 C1 19990826 - GSF FORSCHUNGSZENTRUM UMWELT [DE]
  • WO 9714426 A1 19970424 - UNIV NEBRASKA [US], et al
  • CHU C.T. ET AL: "Complexing antigen to alpha 2-macroglobulin enhances presentation to T cells", J IMMUNOL., vol. 150, no. 1, 1 January 1993 (1993-01-01), pages 48-58
  • CRAWFORD K. ET AL: "Circulating CD2+ monocytes are dendritic cells.", J. IMMUNOL, vol. 163, no. 11, 1 December 1999 (1999-12-01), pages 5920-8
  • WOOD G.S. ET AL: "CD5 monoclonal antibodies react with human peripheral blood dendritic cells.", AM J PATHOL., vol. 141, no. 4, October 1992 (1992-10-01), pages 789-795

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

DOCDB simple family (publication)

WO 03015694 A2 20030227; WO 03015694 A3 20040715; BR 0211926 A 20061212; CA 2457328 A1 20030227; CN 1604792 A 20050406; EP 1461074 A2 20040929; EP 1461074 A4 20060111; JP 2004538330 A 20041224; MX PA04001224 A 20040527; US 2003138434 A1 20030724; US 2005152873 A1 20050714

DOCDB simple family (application)

US 0225511 W 20020812; BR 0211926 A 20020812; CA 2457328 A 20020812; CN 02820220 A 20020812; EP 02752793 A 20020812; JP 2003520455 A 20020812; MX PA04001224 A 20020812; US 14296602 A 20020513; US 267804 A 20041203